Biosino Bio-Technology and Science Incorporation (HKG:8247)

Market Cap	321.25M +282.8%
Revenue (ttm)	205.08M -29.9%
Net Income	-56.91M
EPS	-0.39
Shares Out	144.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,000
Open	2.260
Previous Close	2.260
Day's Range	2.220 - 2.260
52-Week Range	0.570 - 7.000
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1988
• Employees: 450
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8247

Financial Performance

In 2025, HKG:8247's revenue was 184.29 million, a decrease of -29.95% compared to the previous year's 263.07 million. Losses were -51.14 million, 20.2% more than in 2024.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error